SPRINZA Trademark

Trademark Overview


On Wednesday, January 16, 2002, a trademark application was filed for SPRINZA with the United States Patent and Trademark Office. The USPTO has given the SPRINZA trademark a serial number of 78103010. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Sunday, November 13, 2005. This trademark is owned by La Jolla Pharmaceutical Company. The SPRINZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for prevention and treatment of antibody-mediated diseases, namely, systemic lupus erythematosus, RH hemolytic disease of the newborn, antiphospholipid antibody syndrome, Grave's disease, myasthenia gravis, Hashimoto's thyroiditis, pemphigus, autoimmune hemolytic anemia, autoimmune thrombocytopenia purpura, antibody mediated infertility, Sjogre's syndrome, mixed connective tissue disease, glomerulonephritis and Goodpasture's syndrome

General Information


Serial Number78103010
Word MarkSPRINZA
Filing DateWednesday, January 16, 2002
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSunday, November 13, 2005
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 20, 2002

Trademark Statements


Goods and ServicesPharmaceutical preparations for prevention and treatment of antibody-mediated diseases, namely, systemic lupus erythematosus, RH hemolytic disease of the newborn, antiphospholipid antibody syndrome, Grave's disease, myasthenia gravis, Hashimoto's thyroiditis, pemphigus, autoimmune hemolytic anemia, autoimmune thrombocytopenia purpura, antibody mediated infertility, Sjogre's syndrome, mixed connective tissue disease, glomerulonephritis and Goodpasture's syndrome

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 7, 2002
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLa Jolla Pharmaceutical Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameLa Jolla Pharmaceutical Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Wednesday, January 18, 2006ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Wednesday, January 18, 2006ABANDONMENT - NO USE STATEMENT FILED
Wednesday, May 11, 2005EXTENSION 5 GRANTED
Wednesday, May 11, 2005EXTENSION 5 FILED
Wednesday, May 11, 2005TEAS EXTENSION RECEIVED
Friday, November 12, 2004EXTENSION 4 GRANTED
Friday, November 12, 2004EXTENSION 4 FILED
Friday, November 12, 2004TEAS EXTENSION RECEIVED
Tuesday, August 3, 2004CASE FILE IN TICRS
Monday, April 26, 2004ASSIGNED TO EXAMINER
Saturday, March 27, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 11, 2004EXTENSION 3 GRANTED
Friday, January 23, 2004EXTENSION 3 FILED
Friday, January 23, 2004TEAS EXTENSION RECEIVED
Thursday, November 20, 2003EXTENSION 2 GRANTED
Wednesday, November 12, 2003EXTENSION 2 FILED
Wednesday, November 12, 2003TEAS EXTENSION RECEIVED
Saturday, June 7, 2003EXTENSION 1 GRANTED
Monday, May 12, 2003EXTENSION 1 FILED
Monday, May 12, 2003TEAS EXTENSION RECEIVED
Tuesday, November 12, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 20, 2002PUBLISHED FOR OPPOSITION
Wednesday, July 31, 2002NOTICE OF PUBLICATION
Thursday, May 30, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 14, 2002EXAMINERS AMENDMENT MAILED
Monday, May 6, 2002NON-FINAL ACTION MAILED
Thursday, May 2, 2002ASSIGNED TO EXAMINER
Thursday, May 2, 2002ASSIGNED TO EXAMINER